Rhythm Biosciences (ASX:RHY) said that it has retained its ISO 13485:2016 certification for the seventh year from the UK's British Standards Institution (BSI), according to a Monday filing with the Australian bourse.

This year's certification also includes an expanded scope, now covering the design, manufacturing, distribution, installation, and servicing of in-vitro medical devices, the filing said.